Search Results - Jingai Fang
- Showing 1 - 4 results of 4
-
1
-
2
Integrating network pharmacology and experimental validation to explore the pharmacological mechanism of Astragaloside IV in alleviating urotensin II-mediated renal tubular epithel... by Wenyuan Liu, Qianwei Liu, Ziyuan Zhang, Yaling Hu, Jingai Fang
Published in PLoS ONE (2024-01-01)Get full text
Article -
3
Astragaloside IV alleviates renal fibrosis by inhibiting renal tubular epithelial cell pyroptosis induced by urotensin II through regulating the cAMP/PKA signaling pathway. by Lin Zhang, Wenyuan Liu, Sufen Li, Jinjing Wang, Dalin Sun, Hui Li, Ziyuan Zhang, Yaling Hu, Jingai Fang
Published in PLoS ONE (2024-01-01)Get full text
Article -
4
Bupi Yishen Formula Versus Losartan for Non-Diabetic Stage 4 Chronic Kidney Disease: A Randomized Controlled Trial by Wei Mao, Nizhi Yang, Lei Zhang, Chuang Li, Yifan Wu, Wenwei Ouyang, Wenwei Ouyang, Peng Xu, Chuan Zou, Chunpeng Pei, Wei Shi, Jihong Zhan, Hongtao Yang, Hongyu Chen, Xiaoqin Wang, Yun Tian, Fang Yuan, Wei Sun, Guoliang Xiong, Ming Chen, Jianguo Guan, Shuifu Tang, Chunyan Zhang, Chunyan Zhang, Yuning Liu, Yueyi Deng, Qizhan Lin, Fuhua Lu, Weihong Hong, Aicheng Yang, Jingai Fang, Jiazhen Rao, Lixin Wang, Kun Bao, Feng Lin, Yuan Xu, Zhaoyu Lu, Guobin Su, La Zhang, David W Johnson, Daixin Zhao, Haijing Hou, Lizhe Fu, Xinfeng Guo, Lihong Yang, Xindong Qin, Zehuai Wen, Zehuai Wen, Xusheng Liu
Published in Frontiers in Pharmacology (2021-01-01)Get full text
Article
